Research Article
Efficacy and Safety of Ganduqing Granules in Treating the Common Cold: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Table 3
The baseline characteristics of participants.
| | Group | Intervention group (n = 31) (mean ± SD) | Placebo group (n = 29) (mean ± SD) |
| | Male (%) | 23 (74%) | 21 (72%) | | Female (%) | 8 (26%) | 8 (28%) | | BMI (kg/m2) | 22.96 ± 3.096 | 21.85 ± 3.052 | | Age (year) | 40.39 ± 17.16 | 37.69 ± 16.24 | | Height (cm) | 163 ± 6.723 | 163.5 ± 6.780 | | Weight (kg) | 61.05 ± 8.83 | 58.51 ± 9.542 | | Body temperature (°C) | 37.34 ± 0.7051 | 37.49 ± 0.7040 | | Breath (/min) | 17.16 ± 3.551 | 16.93 ± 2.975 | | Heart rate (/min) | 81 ± 12.02 | 78.62 ± 9.796 | | Diastolic pressure (mmHg) | 78.48 ± 9.825 | 79.86 ± 10.89 | | Systolic pressure (mmHg) | 114 ± 13.43 | 110.7 ± 22.18 | | Time from onset to enrollment (h) | 35.61 ± 9.025 | 33 ± 11.62 | | IL-6 | 15.69 ± 30.64 | 14.85 ± 10.42 | | TNF-α | 156.5 ± 118.0 | 153.3 ± 120 | | SOD | 73.45 ± 89.64 | 68.79 ± 46.76 | | MDA | 20.13 ± 20.36 | 19.56 ± 13.40 | | TCM syndrome score | 20.65 ± 6.243 | 25.41 ± 7.023 |
|
|
